Literature DB >> 29502135

Correlation of Patient- and Physician-Scored Dysphagia with Videofluoroscopies in Patients Treated with Radiotherapy for Head and Neck Cancer.

D Nevens1, A Goeleven2, F Duprez3, A Laenen4, E Dejaeger5, W De Neve3, S Nuyts6.   

Abstract

The aim of this study was to investigate the correlation between patient-scored dysphagia and physician-scored dysphagia in head and neck cancer patients treated with radiotherapy. Furthermore, we wanted to compare both patient- and physician-scored dysphagia with dysphagia evaluated on swallowing videofluoroscopies. Sixty-three patients from two different centers treated with radiotherapy for head and neck cancer were evaluated in the current study. Swallowing videofluoroscopies at baseline, 6, and 12 months following radiotherapy were evaluated by 2 observers using the Penetration Aspiration Scale (PAS) and Swallowing Performance Status Scale (SPS) and correlated with patient and physician scored dysphagia. We observed a significant association between physician and patient scored dysphagia (p < 0.01), pre-treatment and post-treatment. Furthermore, the risk of observing dysphagia on videofluoroscopies increased significantly with increasing scores of both physician as well as patient scored dysphagia, and this at all assessed time-points. Patient-scored dysphagia correlates better with dysphagia evaluated by the PAS. Physician-scored dysphagia, however, correlates better with dysphagia as evaluated using the SPS. Both physician- and patient-scored dysphagia correlate well with dysphagia evaluated on videofluoroscopies. Since patient-scored dysphagia correlates better with PAS and changes in the PAS score, and physician-scored dysphagia correlates better with SPS, we advocate to use both patient- and physician-scored dysphagia in future trials.

Entities:  

Keywords:  Dysphagia; Head and neck cancer; PAS; Radiotherapy; SPSS; Videofluoroscopy

Mesh:

Year:  2018        PMID: 29502135     DOI: 10.1007/s00455-018-9888-5

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  26 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Validation of the total dysphagia risk score (TDRS) in head and neck cancer patients in a conventional and a partially accelerated radiotherapy scheme.

Authors:  Daan Nevens; Sarah Deschuymer; Johannes A Langendijk; Jean-François Daisne; Fréderic Duprez; Wilfried De Neve; Sandra Nuyts
Journal:  Radiother Oncol       Date:  2015-10-20       Impact factor: 6.280

3.  Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.

Authors:  Sandra Nuyts; Maarten Lambrecht; Fréderic Duprez; Jean-Francois Daisne; Dirk Van Gestel; Danielle Van den Weyngaert; Nele Platteaux; Yasmyne Geussens; Mia Voordeckers; Indira Madani; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2013-08-13       Impact factor: 6.280

4.  Objective assessment of swallowing function after definitive concurrent (chemo)radiotherapy in patients with head and neck cancer.

Authors:  Jaiprakash Agarwal; Vijay Palwe; Debnarayan Dutta; Tejpal Gupta; Sarbani Ghosh Laskar; Ashwini Budrukkar; Vedang Murthy; Pankaj Chaturvedi; Prathamesh Pai; Devendra Chaukar; Anil K D'Cruz; Suyash Kulkarni; Aniruddha Kulkarni; Gurmit Baccher; Shyam Kishore Shrivastava
Journal:  Dysphagia       Date:  2011-02-23       Impact factor: 3.438

5.  Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.

Authors:  Daan Nevens; Fréderic Duprez; Jean Francois Daisne; Ruveyda Dok; Ann Belmans; Mia Voordeckers; Danielle Van den Weyngaert; Wilfried De Neve; Sandra Nuyts
Journal:  Radiother Oncol       Date:  2016-08-12       Impact factor: 6.280

6.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Authors:  Johannes A Langendijk; Patricia Doornaert; Irma M Verdonck-de Leeuw; Charles R Leemans; Neil K Aaronson; Ben J Slotman
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

7.  The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.

Authors:  Kenneth Jensen; Anders Bonde Jensen; Cai Grau
Journal:  Radiother Oncol       Date:  2006-03-09       Impact factor: 6.280

8.  Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III.

Authors:  Susanne Singer; Cláudia Araújo; Juan Ignacio Arraras; Ingo Baumann; Andreas Boehm; Bente Brokstad Herlofson; Joaquim Castro Silva; Wei-Chu Chie; Sheila Fisher; Orlando Guntinas-Lichius; Eva Hammerlid; María Elisa Irarrázaval; Marianne Jensen Hjermstad; Kenneth Jensen; Naomi Kiyota; Lisa Licitra; Ourania Nicolatou-Galitis; Monica Pinto; Marcos Santos; Claudia Schmalz; Allen C Sherman; Iwona M Tomaszewska; Irma Verdonck de Leeuw; Noam Yarom; Paola Zotti; Dirk Hofmeister
Journal:  Head Neck       Date:  2014-07-21       Impact factor: 3.147

9.  Comparing the Performance Status Scale and MD Anderson Dysphagia Inventory as swallowing outcome measures in head and neck cancer: a prospective cohort study.

Authors:  M K Khan; J Patterson; S Owen; S Rees; L Gamberini; V Paleri
Journal:  Clin Otolaryngol       Date:  2015-08       Impact factor: 2.597

10.  Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation.

Authors:  Katherine A Hutcheson; Martha P Barrow; Denise A Barringer; Jodi K Knott; Heather Y Lin; Randal S Weber; Clifton D Fuller; Stephen Y Lai; Clare P Alvarez; Janhavi Raut; Cathy L Lazarus; Annette May; Joanne Patterson; Justin W G Roe; Heather M Starmer; Jan S Lewin
Journal:  Cancer       Date:  2016-08-26       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.